Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Enterprise Value (2017 - 2026)

Inspire Medical Systems' Enterprise Value history spans 10 years, with the latest figure at -$283.8 million for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 23.12% to -$283.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$283.8 million, a 23.12% increase, with the full-year FY2025 number at -$308.3 million, up 30.81% from a year prior.
  • Enterprise Value hit -$283.8 million in Q1 2026 for Inspire Medical Systems, up from -$308.3 million in the prior quarter.
  • Over the last five years, Enterprise Value for INSP hit a ceiling of -$196.3 million in Q2 2022 and a floor of -$467.1 million in Q2 2023.
  • Historically, Enterprise Value has averaged -$379.1 million across 5 years, with a median of -$427.5 million in 2022.
  • Biggest five-year swings in Enterprise Value: crashed 137.9% in 2023 and later soared 31.56% in 2025.
  • Tracing INSP's Enterprise Value over 5 years: stood at -$451.4 million in 2022, then fell by 1.99% to -$460.4 million in 2023, then increased by 3.22% to -$445.5 million in 2024, then surged by 30.81% to -$308.3 million in 2025, then grew by 7.93% to -$283.8 million in 2026.
  • Business Quant data shows Enterprise Value for INSP at -$283.8 million in Q1 2026, -$308.3 million in Q4 2025, and -$322.6 million in Q3 2025.